Gene · 4669
Papers3,421
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,101 to 1,120 of 3,421
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Interrelationship of environmental melamine exposure, biomarkers of oxidative stress and early kidney injury. | J Hazard Mater | 2020 | 32348942 | PubTator, text mining | PubMed |
| Association between Renal Podocalyxin Expression and Renal Dysfunction in Patients with Diabetic Nephropathy: A Single-Center, Retrospective Case-Control Study. | Biomed Res Int | 2020 | 32337271 | PubTator, text mining | PubMed |
| A cross-sectional analysis of clinicopathologic similarities and differences between Henoch-Schönlein purpura nephritis and IgA nephropathy. | PLoS One | 2020 | 32324811 | PubTator, text mining | PubMed |
| Efficacy and safety of evogliptin treatment in patients with type 2 diabetes: A multicentre, active-controlled, randomized, double-blind study with open-label extension (the EVERGREEN study). | Diabetes Obes Metab | 2020 | 32319168 | PubTator, text mining | PubMed |
| A Case of Acute Kidney Injury in a Patient with Renal Hypouricemia without Intense Exercise. | Case Rep Nephrol Dial | 2020 | 32309296 | PubTator, text mining | PubMed |
| Pharmacological Effects and Toxicogenetic Impacts of Omeprazole: Genomic Instability and Cancer. | Oxid Med Cell Longev | 2020 | 32308801 | PubTator, text mining | PubMed |
| Renal tubular damage and worsening renal function in chronic heart failure: Clinical determinants and relation to prognosis (Bio-SHiFT study). | Clin Cardiol | 2020 | 32298007 | PubTator, text mining | PubMed |
| Biomarkers for Lysosomal Storage Disorders with an Emphasis on Mass Spectrometry. | Int J Mol Sci | 2020 | 32295281 | PubTator, text mining | PubMed |
| Diagnostics, Risk Factors, Treatment and Outcomes of Acute Kidney Injury in a New Paradigm. | J Clin Med | 2020 | 32294894 | PubTator, text mining | PubMed |
| Metabolic maturation in the first 2 years of life in resource-constrained settings and its association with postnatal growths. | Sci Adv | 2020 | 32284996 | PubTator, text mining | PubMed |
| Mechanism of Secondary Ganglioside and Lipid Accumulation in Lysosomal Disease. | Int J Mol Sci | 2020 | 32272755 | PubTator, text mining | PubMed |
| Consensus guidelines for management of hyperammonaemia in paediatric patients receiving continuous kidney replacement therapy. | Nat Rev Nephrol | 2020 | 32269302 | PubTator, text mining | PubMed |
| Acute Kidney Injury with Hemolysis after Glycerin Enema-induced Rectal Injury in a Patient with Type 2 Diabetes. | Intern Med | 2020 | 32269190 | PubTator, text mining | PubMed |
| FDA orphan drug designations for lysosomal storage disorders - a cross-sectional analysis. | PLoS One | 2020 | 32267884 | PubTator, text mining | PubMed |
| Drug Toxicity Evaluation Based on Organ-on-a-chip Technology: A Review. | Micromachines (Basel) | 2020 | 32260191 | PubTator, text mining | PubMed |
| Diagnosis of Mucopolysaccharidoses. | Diagnostics (Basel) | 2020 | 32235807 | PubTator, text mining | PubMed |
| Pembrolizumab-induced hypothyroidism caused reversible increased serum creatinine levels: a case report. | BMC Nephrol | 2020 | 32234009 | PubTator, text mining | PubMed |
| Synthetic antibodies against BRIL as universal fiducial marks for single-particle cryoEM structure determination of membrane proteins. | Nat Commun | 2020 | 32221310 | PubTator, text mining | PubMed |
| In-depth characterization of a novel live-attenuated Mayaro virus vaccine candidate using an immunocompetent mouse model of Mayaro disease. | Sci Rep | 2020 | 32210270 | PubTator, text mining | PubMed |
| Validation of Liquid Chromatography-Tandem Mass Spectrometry-Based 5-Plex Assay for Mucopolysaccharidoses. | Int J Mol Sci | 2020 | 32188102 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4669/papers?page=56